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Tuberculosis is one of the major killers in the world
today and has been descr ibed as a “global
emergency” by WHO. I n  I n d i a  t h e r e  a r e
approximately 1 million new cases every year and
500,000 deaths. Tuberculosis also affects children
who get the infection from adults. It is important to
study the natural history, clinical manifestations and
immunological profile of children in order to diagnose
them earlier and treat them effectively.
T h e  c l i n i c a l  e x p r e s s i o n  o f  i n f e c t i o n  w i t h
Mycobacterium tuberculosis (M.tb) is quite varied and
Among healthy persons, infection with M.tb is
generally asymptomatic as infection is contained by
the host immune system. Only a positive tuberculin
skin test indicates the presence of the organism in
persons with a latent infection. The lifetime risk of
developing clinical disease is approximately 10% (1).
However, in subjects who are immunosuppressed for
any reason e.g. infancy or HIV infection, the
proportion who develop disease is much greater (2).
Age plays a major role and infants who are infected
by a close contact are estimated to have a 40% chance
of developing disease as opposed to adolescents
depends on a number of  factors  (Table 1). whose risk is around 15%.
Table 1
FACTORS INFLUENCING THE CLINICAL FEATURES OF TUBERCULOSIS
Host factors Microbial factors Host-microbe interaction
Age
Immune status
Specific immunodeficiency states
Malnutrition
Genetic factors ?
Coexisting diseases
BCG immunisation
Virulent of org? Sites of involvement
Predilection for specific
tissues Severity of disease
Size of infect particle
No. of tubercle bacilli inhaled
When Robert Koch described the etiologic agent of TB
in 1882, he had noted the intracellullar location of M.
tb within giant cells in granulomatous lesions.
Metchnikoff was the first to fully realise the importance
of macrophages in antibacterial immunity particularly
against TB. Mackaness showed much later that
activation of antimycobacterial macrophage functions
is controlled by lymphocytes (3). That this activation is
mediated by soluble substances, now called cytokines
was noted by B. R. Bloom (4) and J.R.David (5).
There are two arms of the immune system : cellular
and humoral. Cellular immunity is more important
in  dea l i ng  w i th  i n t race l l u la r  o rgan i sms  l i ke
mycobacteria, leishmania, listeria etc. However, the
exact mechanism of protective immunity against TB is
not known. The major cells that play a role are
mononuclear phagocytes (macrophages) and T
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lymphocytes. While macrophages are the principal
effector cells that kill bacteria, T lymphocytes are the
inducers of protection. Both cells also play a dual
role in TB contributing not only to protection but also
to survival of the pathogen (macrophages) and
pathogenesis of the disease (T cells). Coordination
between these two cell types is essential for protection.
lnspite of this, full eradication of the pathogen may
not  be  ach ieved and i t  remains  w i th in  the
grandulomas in a dormant state, which can produce
reactivation disease at a later time.
Numerous glycoproteins, known as CD antigens are
present on the surface of lymphocytes and on other
cells of the immune system and can be used as
phenotypic surface markers to further subcategorize
immunocompetent cells. All native T cells express the
CD2 and CD3 determinants in addition to other
specific CD antigens.
Though the functional property of a given T cell can
generally be inferred from its phenotypic surface
markers, dissociations between classic cell markers
and functions are known to occur. For instance,
though most cytotoxic T cells are CD8+, clones of
CD4+ cytotoxic T cells are known to occur. Thus,
cel l s  with the same phenotype can perform
overlapping or antagonistic functions and cells with
different phenotypes can have the same functional
properties.
T cells recognize antigens through an antigen receptor
composed of alpha and beta or gamma and delta
polypeptide chains known as the T cell receptor (TCR)-
CD3 complex. Changes in the amino acid sequences
of the variable regions of these receptors alter their
shape and confer antigen specificity. Once antigen
is bound to the receptor, signal transduction into the
cytoplasm triggers functions such as cytokine
production and cytolytic activity. Most alpha beta T
cells bear the CD4 or CD8 determinants. CD4+ T
cells recognise antigens associated with self MHC class
II gycoproteins whereas CD8+ alpha beta T cells
recognise antigen in the context of MHC class I
products.
The various cells and their products that are involved
in the killing of M.tb are known but the interplay and
interaction between them is complex. The chief
players are the macrophages and T lymphocytes.
Macrophages must be activated before they can
destroy tubercle bacilli. Activated macrophages
contain many mitochondria and lysosymes and have
high levels of oxidative and digestive enzymes. In
the mouse model, murine macrophages can be
activated to inhibit or destroy virulent M.tb in vitro.
Stimulation with alpha-interferon and either LPS or
TNF causes release of nitric oxide from macrophages
which is required for antimycobacterial activity (6).
Nitric oxide (NO) which is produced from arginine is
now thought to be more important than free oxygen
radicals in killing of M.tb.
However majority of the work done with human
macrophages has not been able to demonstrate
killing of M.tb. even after activation with various
substances. At best a slowing of the intracellular
replication could be achieved following addition of
IFN-gamma and calcitriol. It has also not been able
to demonstrate NO production in vitro by human
macrophages (7) probably because they are unable
to generate tetrahydrobiopterin, an essential cofactor
for arginine dependent NO synthesis.
When tubercle bacilli are inhaled into the lung, they
are engulfed by alveolar macrophages which attempt
to kil l  the bacteria within the phagolysosome.
Macrophages also produce certain specific cytokines
or medaitors including IL-1, IL-6, IL-10, TNF alpha
a n d  T G F  b e t a  ( 8 ) . These cytokines have
immunoregulatory effects and also mediate some of
the clinical manifestations of tuberculosis, e.g. IL-1
cont r ibutes  to  fever ,  I L -6  may mediate  the
hyperglobul inaemia and TNF i s  essent ia l  for
granuloma formation. TNF also causes fever, weight
loss and tissue necrosis. IL-10 inhibits cytokine
production by lymphocytes and TGF-beta suppresses
T cell proliferation. There two cytokines may prevent
excessive inflammation and tissue damage.
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i) CD4+ T cells : CD4+ T cells play a dominant but
not exclusive role in immune defense against TB.
Transfer of CD4+ T cells from sensitised animals
confers protection against tuberculosis. In humans,
CD4+ T cells are selectively expanded at the site of
disease in patients with a resistant immune response
e.g. tuberculous pleuritis (10). In patients with HIV
infection, CD4+ depletion increases the risk of disease
and as the CD4+ counts fall clinical indicators of
severe disease increase.
CD4+ cells can be divided into “naiva” and “memory”
cells based on their expression of CD45. Memory
cells (with prior) exposure to antigen) express the
CD45 RO isoform and are concentrated in the pleural
fluid of patients with TB pleurisy whereas naive T cells
are not (10). Memory T cells also proliferate in
response to M.tb antigens and produce IFN-gamma,
a macrophage activating cytokine suggesting that they
are important in local immune defenses against
tuberculosis.
A few years ago, two distinct sub-populations of CD4+
T cells were described in the mouse that produce
different patterns of cytokines (Table 2). Th1 cells
produce gamma interferon, IL-2 and lymphotoxin and
augment DTH responses and microbicidal capacity
of macrophages. Th2 cells produce IL-4, IL-5, IL-6
and IL-10, support B cell growth and aument humoral
immune responses (11). Th1 cells are considered
important in mediating immunity against intracellular
pathogens whereas Th2 cells play a role in atopic
and parasitic diseases. The two subtypes exert cross
regulatory influences, that favour predominance of
one subtype, in response to a specific pathogen, IL-
12 produced by macrophages and IFN-gamma
produced by natural  k i l ler  (NK) cel l s  favour
development of a Th1 response whereas IL-10
produced by macrophages and IL-4 produced by
CD4+ NK1.1+ cells bias towards a Th2 response
(12). In murine leishmaniasis, Th1 cells mediate
immunologic resistance to infection whereas Th2
exacerbate disease (13).
Table 2
CYTOKINES PRODUCED BY MACROPHAGES AND BY TH1 AND TH2 CELLS
Cytokine
Macrophage
Production by
Th1 Th2
IL-2 +
IFN-gamma +
Lymphotoxin +
IL-4 +
IL-5 +
IL-6 + +
IL-10 + + +
IL-3 + +
GM-CSF + + +
T N F + + +
IL-1 +
IL-8 +
TGF-beta +
Elicits DTH +
IgE production and eosinophilia +
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Human T cells also exhibit patterns of cytokine
production similar to those of murine Th1 and Th2
cells. IL-10 is produced by human Th1 and Th2 cells
both as well as mononuclear phagocytes and inhibits
proliferation and cytokine production by both
subpopulation. Pattern of cytokine production in
humans correlate with clinical manifestations of
infectious disease eg CD4+ T cells from patients with
helminthic infections perferentially produce the Th2
cytokines IL-4 and IL-5 which stimulate IgE production
and eosinophil growth respectively. In patients with
leprosy the Th1 cytokines IL-2 and IFN gamma
predominate in skin lesions of tuberculoid leprosy
patients (resistant immune response) whereas the Th2
cytokines IL-4 and IL-10 are prominent in lepromatous
leprosy patients with ineffective immunity (14).
In patients with tuberculosis also, there is a spectrum
of immune response which correlates broadly with
clinical manifestations. Healthy tuberculin reactors
have protective immunity against disease and
peripheral blood monocytes from such individuals
produce high concentrations of IFN-gamma when
stimulated with M.tb. Monocytes from patients with
pulmonary TB however produce significantly lower
amount of IFN-gamma (15). Finally, in patients with
HIV and tuberculosis who often have extrapulmonary
dissemination, IFN-gamma production is markedly
depressed. Though Th1 responses are depressed in
patients with TB, there is no evidence that Th2
responses are enhanced either systemically or at the
site of disease (16). Recent work has shown that IL-
10 is responsible for the depressed IFN-gamma
response and acts by inhibiting IL-12 production (15).
Neutralization of IL-10 or addition of IL-12 enhances
IFN-gamma production by PBMC from TB patients.
However IL-10 and IL-12 production by antigen
st imulated PBMC from TB pat ients i s  normal,
suggesting that rather than cytokine concentrations,
there may be changes in receptor expression or
signalling pathways.
An alternative mechanism by which T cells contribute
to immune defence is through direct cytolysis of
macrophages and non-phagocytic cells infected with
M.tuberculosis. M.tb specific cytolytic activity of CD4+
cells at the site of disease is greatly enhanced
compared to that of peripheral blood cells. Cytolytic
T cells that recognise mycobacterial antigens can lyse
infected macrophages releasing bacilli which can be
engulfed and killed by macrophages with greater
antimycobacterial activity. They are also thought to
contribute to immunopathology by destroying infected
macrophages which in turn release toxic products that
result in caseous necrosis (17).
CD8+ T cells contribute the major cytolytic T cell
population in defenses against many intracellular
pathogens. C D 4 +  a n d  C D 8 +  T  c e l l s  p l a y
complementary roles in the immune response to M.tb.
CD4+ T cells may produce cytokines that activate
macrophages to kill most mycobacteria and produce
sufficient IL-2 to activate CD8+ T cells, which in turn
lyse additional mycobacterium infected cells.
However ,  the  ro le  o f  CD8+  ce l l s  i n  human
antimycobacterial defenses remains uncertain. CD8+
T cells are not selectively concentrated at the site of
disease and the severity of TB in HIV infected patients
is unaffected by the CD8 cell count. More
comprehensive studies are needed to assess the role
of CD8+ T cells in human anti TB defenses.
T cells bearing the gamma delta receptor account for
a minority (<5%) of cells in peripheral blood, the
majority being alpha beta positive. Gamma delta T
cells proliferate in response to mycobacterial antigens,
are cytotoxic and secrete a pattern of cytokines similar
to Th1 cells (18). The percentage of gamma delta T
cells is greatly increased in draining lymphnodes and
lungs of mice after primary infection with M.tb.
Expansion of M.tb-reactive gamma delta T cells is
greater in healthy tuberculin reactors and in patients
with tuberculous pleuritis than in those with advanced
plumonary and miliary TB suggesting that they
contribute to immune resistance. although the exact
role played by these cells is not known, it is thought
that they contribute to control of primary infection
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and may be important in the early phase of the
immune response before the alpha beta T cell
response has become established.
The study of tuberculous infection in children provides
a unique opportunity to evaluate the primary human
immune response to infection. Children infected with
tubercle bacilli can remain healthy tuberculin reactors,
develop uncomplicated primary tuberculosis or suffer
severe complications such as miliary or meningeal
tuberculosis. We have evaluated the lymphocyte
subsets in blood and BAL fluid in children with primary
tuberculosis (Table 3 and 4). In the blood, we found
the total lymphocyte count as well as the CD3 and
CD4 count and percentage to be decreased in children
with TB compared to healthy tuberculin positive
controls. This could indicate that either the T cells
are sequestrated at the site of disease (in the lung) or
that there is a suppression of cell mediated immune
response during active TB.
In the bronchoalveolar lavage fluid (which represents
the alveolar environment), the percentage of
lymphocytes and eosinophils was significantly
increased and macrophages proportionately reduced
in children with TB. This adds weight to the hypothesis
that activated lymphocytes are sequestered at the site
of disease. Further studies are required to determine
which subtype these cells belong to and what cytokines
they produce.
Table 3
LYMPHOCYTE SUBSETS IN BLOOD
CD3* CD4* CD8* Gamma
Delta
T B 6 3 ± 1 3 % 3 3 ± 1 0 % 2 7 ± 8 % 7 ± 4 %
(n=22)
PPD+
( n = l 7 )
7 0 ± 7 % 3 8 ± 9 % 2 1 ± 5 % 8 ± 6 %
*p<0.05
Table 4
CELLULAR PROFILE OF BAL FLUID IN PULMONARY TUBERCULOSIS
T B
( n = l 8 )
Total Count
(106/100ml
7 5 ± 4 5
Macrophages
%
5 6 ± 2 5 *
Lymph
%
2 2 ± 1 7 *
Eosin
%
1 0 ± 1 7 . 5 *
CONTROLS
(Ronchetti et al)
8 0 ± 8 4 8 4 ± 8 1 0 ± 6 0
*p<0.02
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The humoral immune response in tuberculosis does
not play a role in controlling the infection. However,
immunodiagnosis using different antigens from M.
Tuberculosis has been attempted for the last 100
years. There are a number of crude, semipurified
and, highly purified antigens that have been proposed
as useful antigens for diagnosis. The only M.tb
specific antigens shown to date are the 38kDa of
lvanyi (19) and 14kDa (20). Only a small number of
monoclonal antibodies are M. tuberculous specific
(TB 23, 68, 71, 78) (28). The value of a serodiagnostic
test depends on its sensitivity (number of positive tests
out of total number of true cases) and specificity
(number of negative tests out of the total number of
control samples). Whether antibodies develop to a
particular antigen will depend on its immunogenecity,
dose and duration of exposure and possibly the
genetic make up of the host. Also, with “natural
exposure” to environmental mycobacteria antibodies
develop to common mycobacterial antigens which
could cross react with the test antigen (21).
Reported studies on serodiagnostic tests for TB in
children have given conflicting results (Table 5) Turneer
Table 5
SERODIOAGNOSTIC STUDIES FOR TB IN CHILDREN
Reference
Delacourt
(1993)
Rosen
(1990)
Barrera
(1989)
Alde
(1989)
Test
Antigen 60
(IgG)
Mycobact.
Sonicates
PPD
Angigen 5
Population
Pulm. TB
Pulm. TB
Bacteriologically
confirmed cases
Sensitivity Specificity
0.67 0.98
0.21 0.40
0.51 0.98
0.85 1.00
Turneer
(1994)
Seth
(1997)
Swaminathan
(1997)
Antigen 60
(IgG)
PPD80
38kDa
(IgG)
Antigen 60
Pulm. TB.
Pulm. Primary
complex
Pulm. TB
0.14 0.95
0.86 0.92
0.47 0.73
0.28 0.86
et al  d id not f ind the ant i  A60 IgM and IgG observed in 68% of children with clinically active TB
measurements useful in the diagnosis of primary TB (23). The IgM test however had a low sensitivity of
or mycobacterial adenitis in children (22). Delacourt 19%. They also found that the IgG antibody values
et al found that using the anti-A60-IgG test and a were influenced by BCG vaccination and age,
specificity of 98% a positive serodiagnosis was increasing with both.
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Rosen used mycobacterial sonicates but sensitivity and
specificity were poor, essentially due to cross reactivity
with BCG (24). Barrea et al had better results using
purified protein derivative and showing a specificity
of 98% and a sensitivity of 51% in bacteriologically
confirmed cases (25). The best results were obtained
by Alde et al using antigen 5 which is the same as the
38kDa antigne (26). They found a specificity of 100%
and sensitivity of 85.7% in bacteriologically confirmed
tuberculous children but the number of control subjects
was low in that study. We studied the role of Anda
(A60) antigen and the Pathozyme TB Complex (38kDa)
antigen in the diagnosis of children with TB and got
disappointing results. Even in children with culture
proved tuberculosis, the A60 IgG test was positive only
in 30% and the 38 kDa antibody test was positive in
50% of cases (27).
In children antibody. levels to M.tb antigens are
g e n e r a l l y  l o w e r  t h a n  i n  a d u l t s .  S u c h  a
hyporesponsiveness could be due to the nature of
exposure, extent of disease, immuno competence and
genetic background of the children16. The presence
of cross reacting antibodies will also depend on the
enviornment the child lives in. Hence studies done in
commercially available serodiagnostic kits can be
answered only by testing children in whom the
diagnosis has been confirmed. In our study the kits
tested did not diagnose all those children in whom TB
was bacteriologically confirmed. At the same time
the kits gave positive results in a significant number
of healthy (control) children. Hence they cannot be
recommended for routine diagnostic use.
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